{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:01:12Z","timestamp":1792098072470,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY014943"],"award-info":[{"award-number":["EY014943"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.ophtha.2009.06.060","type":"journal-article","created":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T09:55:23Z","timestamp":1260179723000},"page":"356-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Cyclophosphamide for Ocular Inflammatory Diseases"],"prefix":"10.1016","volume":"117","author":[{"given":"Siddharth S.","family":"Pujari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Gangaputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebenezer","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2009.06.060_bib1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/0002-9394(51)90032-3","article-title":"The use of ACTH and cortisone in ophthalmology","volume":"34","author":"Gordon","year":"1951","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib2","series-title":"Diagnosis and Treatment of Uveitis","first-page":"142","article-title":"Treatment of uveitis: overview","author":"Foster","year":"2002"},{"key":"10.1016\/j.ophtha.2009.06.060_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib4","first-page":"173","article-title":"Nitrogen mustard therapy of uveitis of unknown etiology [undetermined language]","volume":"44","author":"Roda Perez","year":"1952","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.ophtha.2009.06.060_bib5","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0039-6257(91)90186-J","article-title":"Immunosuppressive drugs in immune and inflammatory ocular disease","volume":"35","author":"Hemady","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib6","first-page":"586","article-title":"Immunosuppressive drugs","volume":"vol. 69","author":"Gery","year":"1984"},{"key":"10.1016\/j.ophtha.2009.06.060_bib7","first-page":"2265","article-title":"Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis [in Dutch]","volume":"147","author":"Tervaert","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.ophtha.2009.06.060_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00002281-199102000-00003","article-title":"Wegener's granulomatosis","volume":"3","author":"Leavitt","year":"1991","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib9","first-page":"217","article-title":"Ocular manifestations of Wegener's granulomatosis: analysis of nine cases","volume":"51","author":"Biswas","year":"2003","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/bjo.75.4.201","article-title":"Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease","volume":"75","author":"Charles","year":"1991","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/rheumatology\/40.9.1066","article-title":"Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide [letter]","volume":"40","author":"Cuende","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ophtha.2009.06.060_bib12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","article-title":"Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years","volume":"98","author":"Fauci","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2009.06.060_bib13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/art.1780370622","article-title":"Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis","volume":"37","author":"Reinhold-Keller","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2009.06.060_bib14","first-page":"223","article-title":"Diagnosis and therapy of Wegener's granulomatosis based on ocular changes [in Czech]","volume":"53","author":"Rihova","year":"1997","journal-title":"Cesk Slov Oftalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00003495-199856030-00003","article-title":"Disease-modifying antirheumatic drugs: using their clinical pharmacological effects as a guide to their selection","volume":"56","author":"Jackson","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.ophtha.2009.06.060_bib16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.berh.2007.05.007","article-title":"Extra-articular manifestations and complications of rheumatoid arthritis","volume":"21","author":"Young","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib17","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11926-005-0039-2","article-title":"Polyarteritis nodosa revisited","volume":"7","author":"Colmegna","year":"2005","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ophtha.2009.06.060_bib18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.lpm.2007.01.030","article-title":"Microscopic polyangiitis [in French]","volume":"36","author":"Pagnoux","year":"2007","journal-title":"Presse Med"},{"key":"10.1016\/j.ophtha.2009.06.060_bib19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jbspin.2006.09.003","article-title":"Treatment of systemic lupus erythematosus in 2006","volume":"73","author":"Sibilia","year":"2006","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.ophtha.2009.06.060_bib20","first-page":"98","article-title":"New concepts for the therapy of systemic lupus erythematosus [in French]","volume":"3","author":"Spertini","year":"2007","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.ophtha.2009.06.060_bib21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archderm.138.3.380","article-title":"Interventions for mucous membrane pemphigoid\/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review","volume":"138","author":"Kirtschig","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ophtha.2007.04.027","article-title":"Immunosuppressive therapy for ocular mucous membrane pemphigoid: strategies and outcomes","volume":"115","author":"Saw","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/bjo.79.3.264","article-title":"Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid","volume":"79","author":"Elder","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s003470170182","article-title":"Immunology-related chronic progressive cicatricial conjunctival diseases: diagnosis, therapy and prognosis [in German]","volume":"98","author":"Marx","year":"2001","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ophtha.2009.06.060_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib26","first-page":"101","article-title":"Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide [letter]","volume":"137","author":"Musette","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0248-8663(02)00021-8","article-title":"Severe Moorens ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment [in French]","volume":"24","author":"Tiev","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ophtha.2009.06.060_bib28","first-page":"148","article-title":"Long-term effects of cyclophosphamide and colchicine treatment in Behcet's disease","volume":"23","author":"Kazokoglu","year":"1991","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib29","first-page":"225","article-title":"The eighth Frederick H. Verhoeff Lecture, presented by Saiichi Mishima, MD. Behcet's disease in Japan: ophthalmologic aspects","volume":"77","author":"Mishima","year":"1979","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2009.06.060_bib30","first-page":"508","article-title":"Treatment of Behcet's disease with cyclophosphamide [in Japanese]","volume":"77","author":"Oniki","year":"1973","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1016\/j.ophtha.2009.06.060_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(05)80105-5","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"39","author":"Moorthy","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0181-5512(05)81020-4","article-title":"Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome [in French]","volume":"28","author":"Touitou","year":"2005","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib34","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"1587","article-title":"Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones","author":"Schimmer","year":"2006"},{"key":"10.1016\/j.ophtha.2009.06.060_bib35","first-page":"91","article-title":"Analysis of Survival Data","author":"Cox","year":"1984"},{"key":"10.1016\/j.ophtha.2009.06.060_bib36","first-page":"527","article-title":"Cicatricial pemphigoid","volume":"84","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2009.06.060_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9394(14)77908-5","article-title":"Immunosuppressive therapy in ocular cicatricial pemphigoid","volume":"96","author":"Mondino","year":"1983","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib38","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1016\/j.ophtha.2008.08.002","article-title":"Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy","volume":"115","author":"Thorne","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib39","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ophtha.2003.08.034","article-title":"Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety","volume":"111","author":"Durrani","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0002-9394(14)76823-0","article-title":"Therapy of scleritis with cytotoxic agents","volume":"86","author":"Jampol","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib41","first-page":"123","article-title":"Treatment of severe refractory uveitis with intravenous cyclophosphamide","volume":"21","author":"Rosenbaum","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib42","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib43","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.76.4.241","article-title":"Low dose cyclosporin A versus pulsed cyclophosphamide in Behcet's syndrome: a single masked trial","volume":"76","author":"Ozyazgan","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib45","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","article-title":"A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis","volume":"40","author":"Guillevin","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2009.06.060_bib46","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/096120339700600307","article-title":"Side-effects of intravenous cyclophosphamide pulse therapy","volume":"6","author":"Martin","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.ophtha.2009.06.060_bib47","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00006982-199515030-00004","article-title":"Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus","volume":"15","author":"Neumann","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2009.06.060_bib49","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0161-6420(93)31405-3","article-title":"Ocular presentation of polyarteritis nodosa: clinical course and management with steroid and cytotoxic therapy","volume":"100","author":"Akova","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib50","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis: effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib51","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00003226-199507000-00010","article-title":"Destructive corneal and scleral disease associated with rheumatoid arthritis: medical and surgical management","volume":"14","author":"Messmer","year":"1995","journal-title":"Cornea"},{"key":"10.1016\/j.ophtha.2009.06.060_bib52","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(72)90358-3","article-title":"Sterility and testicular atrophy related to cyclophosphamide therapy","volume":"1","author":"Fairley","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.ophtha.2009.06.060_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0161-6420(83)34600-5","article-title":"Ocular toxicity of antineoplastic agents","volume":"90","author":"Fraunfelder","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2009.06.060_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/RHU.0b013e31817a7e30","article-title":"Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature","volume":"14","author":"Gupta","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1191\/0961203304lu1063oa","article-title":"Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy","volume":"13","author":"Park","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.ophtha.2009.06.060_bib56","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib57","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer-related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2009.06.060_bib58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/ard.42.4.368","article-title":"The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up","volume":"42","author":"Baltus","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2009.06.060_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide: long-term case-control follow-up study","volume":"83","author":"Baker","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2009.06.060_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0897.1992.tb00778.x","article-title":"Treatment with immunosuppressive and disease modifying drugs during pregnancy and lactation","volume":"28","author":"Ostensen","year":"1992","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib61","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/tcm.1770080403","article-title":"Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide","volume":"8","author":"Porter","year":"1988","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.ophtha.2009.06.060_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004397-198902930-00006","article-title":"Complications of corticosteroid and immunosuppressive drugs","volume":"29","author":"Rubin","year":"1989","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ophtha.2009.06.060_bib63","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data: results of the first international workshop","volume":"140","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2009.06.060_bib64","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Dutch Co-trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2009.06.060_bib65","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200008)43:8<1841::AID-ANR21>3.0.CO;2-Q","article-title":"Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy","volume":"43","author":"Chung","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009007350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642009007350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:58:46Z","timestamp":1758981526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642009007350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0161642009007350"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.060","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclophosphamide for Ocular Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2009.06.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}